ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 15 for:    Ad26.Filo
Previous Study | Return to List | Next Study

A Study to Evaluate Safety, Tolerability, and Immunogenicity of Heterologous Prime-boost Regimens Using the Multivalent Filovirus Vaccines Ad26.Filo and MVA-BN-Filo Administered in Different Sequences and Schedules in Healthy Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02860650
Recruitment Status : Completed
First Posted : August 9, 2016
Last Update Posted : February 5, 2018
Sponsor:
Collaborator:
National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by (Responsible Party):
Janssen Vaccines & Prevention B.V.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2017
  Actual Study Completion Date : January 2018